NCT06668493
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06668493
Title Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis (LUNAR)
Acronym LUNAR
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ferring Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University RECRUITING Indianapolis Indiana 46202 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University of Pennsylvania - Perelman Center for Advanced Medicine - Penn Urology RECRUITING Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center - Genitourinary (GU) Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field